In-depth investigation of the underlying mechanisms by which sPD-1 influences immune dysregulation would provide valuable insights into the pathogenesis of type 1 diabetes and potentially open new avenues for therapeutic interventions. Here, HOXD13 is linked to type 1 diabetes mellitus.